Data:
{
"symbol": "CADL",
"price": 11.81,
"marketCap": 865321062,
"beta": -0.502,
"lastDividend": 0,
"range": "4.35-11.93",
"change": 0.01,
"changePercentage": 0.08474576,
"volume": 1679674,
"averageVolume": 1814854,
"companyName": "Candel Therapeutics, Inc.",
"currency": "USD",
"cik": "0001841387",
"isin": "US1374041093",
"cusip": "137404109",
"exchangeFullName": "NASDAQ Global Market",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.candeltx.com",
"description": "Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung cancers, and has progressed to Phase III for prostate cancer. This therapy also successfully completed Phase Ib/II trials for high-grade glioma. Furthermore, the company is advancing CAN-3110, an investigational therapy currently in Phase I clinical trials for recurrent glioblastoma. Established in 2003, the company operated as Advantagene, Inc. until November 2020, when it rebranded as Candel Therapeutics, Inc.",
"ceo": "Paul-Peter Tak",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "55",
"phone": "617 916 5445",
"address": "117 Kendrick Street",
"city": "Needham",
"state": "MA",
"zip": "02494",
"image": "https://images.financialmodelingprep.com/symbol/CADL.png",
"ipoDate": "2021-07-27",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "CADL",
"name": "Candel Therapeutics, Inc.",
"price": 11.8,
"changePercentage": 0,
"change": 0,
"volume": 1679130,
"dayLow": 11.05,
"dayHigh": 11.935,
"yearHigh": 11.93,
"yearLow": 4.35,
"marketCap": 864588360,
"priceAvg50": 9.6158,
"priceAvg200": 6.76848,
"exchange": "NASDAQ",
"open": 11.745,
"previousClose": 11.8,
"timestamp": 1786736870,
"chart_vwap_daily": [
{
"t": "2026-07-06",
"v": 10.1799,
"c": 10.03
},
{
"t": "2026-07-07",
"v": 9.7924,
"c": 9.85
},
{
"t": "2026-07-08",
"v": 9.7258,
"c": 9.88
},
{
"t": "2026-07-09",
"v": 9.8778,
"c": 9.89
},
{
"t": "2026-07-10",
"v": 9.4547,
"c": 9.49
},
{
"t": "2026-07-13",
"v": 9.6594,
"c": 9.64
},
{
"t": "2026-07-14",
"v": 9.8984,
"c": 9.87
},
{
"t": "2026-07-15",
"v": 9.7194,
"c": 9.64
},
{
"t": "2026-07-16",
"v": 9.4073,
"c": 9.48
},
{
"t": "2026-07-17",
"v": 10.2015,
"c": 10.18
},
{
"t": "2026-07-20",
"v": 9.8896,
"c": 9.57
},
{
"t": "2026-07-21",
"v": 10.1641,
"c": 10.22
},
{
"t": "2026-07-22",
"v": 10.0786,
"c": 10.09
},
{
"t": "2026-07-23",
"v": 9.9279,
"c": 9.86
},
{
"t": "2026-07-24",
"v": 9.6367,
"c": 9.56
},
{
"t": "2026-07-27",
"v": 10.024,
"c": 9.96
},
{
"t": "2026-07-28",
"v": 9.7416,
"c": 9.68
},
{
"t": "2026-07-29",
"v": 9.4331,
"c": 9.4
},
{
"t": "2026-07-30",
"v": 9.7438,
"c": 9.87
},
{
"t": "2026-07-31",
"v": 9.9881,
"c": 10.01
},
{
"t": "2026-08-03",
"v": 9.9546,
"c": 10.07
},
{
"t": "2026-08-04",
"v": 10.3726,
"c": 10.51
},
{
"t": "2026-08-05",
"v": 10.4801,
"c": 10.46
},
{
"t": "2026-08-06",
"v": 10.6024,
"c": 10.58
},
{
"t": "2026-08-07",
"v": 10.6059,
"c": 10.59
},
{
"t": "2026-08-10",
"v": 10.4889,
"c": 10.5
},
{
"t": "2026-08-11",
"v": 10.5775,
"c": 10.65
},
{
"t": "2026-08-12",
"v": 10.7003,
"c": 10.68
},
{
"t": "2026-08-13",
"v": 11.3757,
"c": 11.8
},
{
"t": "2026-08-14",
"v": 11.6111,
"c": 11.84
}
],
"vwap_summary": {
"days": 30,
"days_above": 15,
"days_below": 15,
"pct_days_above": 50,
"position": "above",
"gap_pct": 1.97,
"streak_days": 2
}
}
Data:
{
"volume": 1679130,
"avgVolume": 1814854,
"short_ratio": [
{
"symbol": "CADL",
"file_date": "2026-08-13",
"date": "20260813",
"short_volume": 384748,
"short_exempt_volume": 7906,
"total_volume": 967748,
"short_volume_ratio": 0.3976,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 10.07,
"vah": 10.68,
"val": 9.51,
"profile": [
{
"price": 9.22,
"volume": 92302
},
{
"price": 9.27,
"volume": 45669
},
{
"price": 9.31,
"volume": 139197
},
{
"price": 9.36,
"volume": 278581
},
{
"price": 9.4,
"volume": 235094
},
{
"price": 9.45,
"volume": 235934
},
{
"price": 9.49,
"volume": 172285
},
{
"price": 9.54,
"volume": 254522
},
{
"price": 9.58,
"volume": 370330
},
{
"price": 9.63,
"volume": 220127
},
{
"price": 9.67,
"volume": 488562
},
{
"price": 9.72,
"volume": 889185
},
{
"price": 9.76,
"volume": 554656
},
{
"price": 9.8,
"volume": 478231
},
{
"price": 9.85,
"volume": 589871
},
{
"price": 9.89,
"volume": 700182
},
{
"price": 9.94,
"volume": 622728
},
{
"price": 9.98,
"volume": 703715
},
{
"price": 10.03,
"volume": 468013
},
{
"price": 10.07,
"volume": 1234788
},
{
"price": 10.12,
"volume": 523066
},
{
"price": 10.16,
"volume": 557709
},
{
"price": 10.21,
"volume": 532884
},
{
"price": 10.25,
"volume": 306312
},
{
"price": 10.3,
"volume": 191832
},
{
"price": 10.34,
"volume": 302039
},
{
"price": 10.39,
"volume": 267498
},
{
"price": 10.43,
"volume": 389415
},
{
"price": 10.48,
"volume": 431067
},
{
"price": 10.52,
"volume": 563636
},
{
"price": 10.57,
"volume": 886609
},
{
"price": 10.61,
"volume": 944287
},
{
"price": 10.66,
"volume": 824635
},
{
"price": 10.7,
"volume": 410244
},
{
"price": 10.75,
"volume": 293511
},
{
"price": 10.79,
"volume": 263690
},
{
"price": 10.83,
"volume": 128144
},
{
"price": 10.88,
"volume": 35369
},
{
"price": 10.92,
"volume": 0
},
{
"price": 10.97,
"volume": 0
},
{
"price": 11.01,
"volume": 41856
},
{
"price": 11.06,
"volume": 32823
},
{
"price": 11.1,
"volume": 64228
},
{
"price": 11.15,
"volume": 200287
},
{
"price": 11.19,
"volume": 101448
},
{
"price": 11.24,
"volume": 199013
},
{
"price": 11.28,
"volume": 166047
},
{
"price": 11.33,
"volume": 268833
},
{
"price": 11.37,
"volume": 196438
},
{
"price": 11.42,
"volume": 273168
},
{
"price": 11.46,
"volume": 73119
},
{
"price": 11.51,
"volume": 108802
},
{
"price": 11.55,
"volume": 53373
},
{
"price": 11.6,
"volume": 124482
},
{
"price": 11.64,
"volume": 154490
},
{
"price": 11.69,
"volume": 371901
},
{
"price": 11.73,
"volume": 221545
},
{
"price": 11.77,
"volume": 221279
},
{
"price": 11.82,
"volume": 384553
},
{
"price": 11.86,
"volume": 57828
}
],
"sessions": 20
}
}
Data:
{
"symbol": "CADL",
"marketCap": 865321062,
"enterpriseValueTTM": 713273062,
"evToSalesTTM": 0,
"evToOperatingCashFlowTTM": -12.731789836317228,
"evToFreeCashFlowTTM": -12.443703105373343,
"evToEBITDATTM": -9.807945960068203,
"netDebtToEBITDATTM": 2.090754083933777,
"currentRatioTTM": 16.094442254631453,
"incomeQualityTTM": 0.6328065875230146,
"grahamNumberTTM": null,
"grahamNetNetTTM": 1.612626710937168,
"taxBurdenTTM": 1,
"interestBurdenTTM": 1.9045068301602668,
"workingCapitalTTM": 191473000,
"investedCapitalTTM": 194950000,
"returnOnAssetsTTM": -0.42532512767296504,
"operatingReturnOnAssetsTTM": -0.35110676495906784,
"returnOnTangibleAssetsTTM": -0.42532512767296504,
"returnOnEquityTTM": -0.8937898310218195,
"returnOnInvestedCapitalTTM": -0.3674314150823019,
"returnOnCapitalEmployedTTM": -0.3682979986084394,
"earningsYieldTTM": -0.10112167901299006,
"freeCashFlowYieldTTM": -0.06624130917086125,
"capexToOperatingCashFlowTTM": -0.02315120575477929,
"capexToDepreciationTTM": 1.9129793510324484,
"capexToRevenueTTM": 0,
"salesGeneralAndAdministrativeToRevenueTTM": 0,
"researchAndDevelopementToRevenueTTM": 0,
"stockBasedCompensationToRevenueTTM": 0,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 0,
"averagePayablesTTM": 4095000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 0,
"daysOfPayablesOutstandingTTM": 0,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 0,
"cashConversionCycleTTM": 0,
"freeCashFlowToEquityTTM": -52320000,
"freeCashFlowToFirmTTM": -55754000,
"tangibleAssetValueTTM": 126130000,
"netCurrentAssetValueTTM": 122139000,
"grossProfitMarginTTM": 0,
"ebitMarginTTM": 0,
"ebitdaMarginTTM": 0,
"operatingProfitMarginTTM": 0,
"pretaxProfitMarginTTM": 0,
"continuousOperationsProfitMarginTTM": 0,
"netProfitMarginTTM": 0,
"bottomLineProfitMarginTTM": 0,
"receivablesTurnoverTTM": 0,
"payablesTurnoverTTM": 0,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0,
"assetTurnoverTTM": 0,
"quickRatioTTM": 16.094442254631453,
"solvencyRatioTTM": -1.0732147429254197,
"cashRatioTTM": 15.890027591643674,
"priceToEarningsRatioTTM": -8.375886524822695,
"priceToEarningsGrowthRatioTTM": 0.10296989852494896,
"forwardPriceToEarningsGrowthRatioTTM": 0.3282497274125518,
"priceToEarningsDilutedRatioTTM": -8.375886524822695,
"priceToEarningsDilutedGrowthRatioTTM": 0.10296989852494896,
"priceToBookRatioTTM": 6.9411703360818215,
"priceToSalesRatioTTM": 0,
"priceToFreeCashFlowRatioTTM": -15.096319993021634,
"priceToOperatingCashFlowRatioTTM": -15.627328320332722,
"debtToAssetsRatioTTM": 0.2378920869185055,
"debtToEquityRatioTTM": 0.3925870133988742,
"debtToCapitalRatioTTM": 0.2819120167153438,
"longTermDebtToCapitalRatioTTM": 0.2749524318669127,
"financialLeverageRatioTTM": 1.6502735273130897,
"workingCapitalTurnoverRatioTTM": 0,
"operatingCashFlowRatioTTM": -4.416476152936539,
"operatingCashFlowSalesRatioTTM": 0,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0231512057547794,
"debtServiceCoverageRatioTTM": -46.43933588761175,
"interestCoverageRatioTTM": -45.96998722860792,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -1.131389219863885,
"capitalExpenditureCoverageRatioTTM": -43.19429452582884,
"dividendPaidAndCapexCoverageRatioTTM": -43.19429452582884,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0,
"netIncomePerShareTTM": -1.1942470291434126,
"interestDebtPerShareTTM": 0.6890888049353667,
"cashPerShareTTM": 2.71902951993417,
"bookValuePerShareTTM": 1.7014421816748782,
"tangibleBookValuePerShareTTM": 1.7014421816748782,
"shareholdersEquityPerShareTTM": 1.7014421816748782,
"operatingCashFlowPerShareTTM": -0.755727387171741,
"capexPerShareTTM": 0.017496000234934726,
"freeCashFlowPerShareTTM": -0.7732233874066758,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 1.22978510605787,
"priceToFairValueTTM": 6.9411703360818215,
"debtToMarketCapTTM": 0.05527543717640378,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -9.807945960068203,
"dividendPerShareTTM": 0,
"revenue_history": [],
"dcf": {
"symbol": "CADL",
"date": "2026-08-14",
"dcf": 2.2046969203643774,
"Stock Price": 11.695
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "CADL",
"reportedCurrency": "USD",
"cik": "0001841387",
"filingDate": "2026-03-12",
"acceptedDate": "2026-03-12 08:17:10",
"fiscalYear": "2025",
"period": "FY",
"revenue": 0,
"costOfRevenue": 0,
"grossProfit": 0,
"researchAndDevelopmentExpenses": 30496000,
"generalAndAdministrativeExpenses": 17770000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 17770000,
"otherExpenses": 0,
"operatingExpenses": 48266000,
"costAndExpenses": 48266000,
"netInterestIncome": 1796000,
"interestIncome": 3915000,
"interestExpense": 2119000,
"depreciationAndAmortization": 845000,
"ebitda": -35218000,
"ebit": -36063000,
"nonOperatingIncomeExcludingInterest": -12203000,
"operatingIncome": -48266000,
"totalOtherIncomeExpensesNet": 10084000,
"incomeBeforeTax": -38182000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -38182000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -38182000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -38182000,
"eps": -0.72,
"epsDiluted": -0.72,
"weightedAverageShsOut": 52958644,
"weightedAverageShsOutDil": 52958644
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "CADL",
"reportedCurrency": "USD",
"cik": "0001841387",
"filingDate": "2026-03-12",
"acceptedDate": "2026-03-12 08:17:10",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 119731000,
"shortTermInvestments": 0,
"cashAndShortTermInvestments": 119731000,
"netReceivables": 0,
"accountsReceivables": 0,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 0,
"totalCurrentAssets": 119731000,
"propertyPlantEquipmentNet": 0,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 416000,
"taxAssets": 0,
"otherNonCurrentAssets": 5048000,
"totalNonCurrentAssets": 5464000,
"otherAssets": 0,
"totalAssets": 125195000,
"totalPayables": 1129000,
"accountPayables": 1129000,
"otherPayables": 0,
"accruedExpenses": 0,
"shortTermDebt": 445000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 7423000,
"totalCurrentLiabilities": 8997000,
"longTermDebt": 1459000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 62817000,
"totalNonCurrentLiabilities": 64276000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 73273000,
"treasuryStock": -448000,
"preferredStock": 0,
"commonStock": 550000,
"retainedEarnings": -230387000,
"additionalPaidInCapital": 282207000,
"accumulatedOtherComprehensiveIncomeLoss": 0,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 51922000,
"totalEquity": 51922000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 125195000,
"totalInvestments": 416000,
"totalDebt": 1904000,
"netDebt": -117827000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "CADL",
"reportedCurrency": "USD",
"cik": "0001841387",
"filingDate": "2026-03-12",
"acceptedDate": "2026-03-12 08:17:10",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -38182000,
"depreciationAndAmortization": 845000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 3817000,
"changeInWorkingCapital": 2193000,
"accountsReceivables": 0,
"inventory": 0,
"accountsPayables": 802000,
"otherWorkingCapital": 1391000,
"otherNonCashItems": -6984000,
"netCashProvidedByOperatingActivities": -38311000,
"investmentsInPropertyPlantAndEquipment": -587000,
"acquisitionsNet": 27000,
"purchasesOfInvestments": 0,
"salesMaturitiesOfInvestments": 0,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -560000,
"netDebtIssuance": 36213000,
"longTermNetDebtIssuance": 36213000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 19885000,
"netCommonStockIssuance": 19885000,
"commonStockIssuance": 19885000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 56098000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 17227000,
"cashAtEndOfPeriod": 120147000,
"cashAtBeginningOfPeriod": 102920000,
"operatingCashFlow": -38311000,
"capitalExpenditure": -587000,
"freeCashFlow": -38898000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 11.7661,
"rsi": 72.11824678430347,
"sma20": 10.291305,
"sma50": 9.675122000000002,
"sma200": 6.8003304999999985,
"adx": 22.72958186032659,
"atr": 0.55,
"atr_pct": 4.67,
"high_52w": 14,
"low_52w": 0.6751,
"structure": {
"ema8": 10.988514615089496,
"ema21": 10.430527744117972,
"ema50": 9.667410711495346,
"ema200": 7.5471112655622985,
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": 12.8,
"macd": {
"macd": 0.472,
"signal": 0.337,
"histogram": 0.135
},
"bollinger": {
"mid": 10.29,
"upper": 11.55,
"lower": 9.03,
"width_pct": 24.42
},
"crossover": {
"fresh_cross": false,
"pre_compressed": true,
"held_above_21": false,
"candles_since": 84,
"intraday_support": false
},
"momentum": {
"roc10": 17.5,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 1.37,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": true,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 2.97,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": false,
"mcap_over_1b": false,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 21433425.740000002,
"avg_vol": 1814854
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 1.3,
"iv_rank": 30.0
}
}
}
}
Data:
{
"prior_day": {
"high": 11.93,
"low": 11.04,
"close": 11.84,
"date": "2026-08-14"
},
"woodie_pivots": {
"PP": 11.66,
"R1": 12.29,
"S1": 11.39,
"R2": 12.55,
"S2": 10.77
},
"swing": {
"high_20d": 11.93,
"low_20d": 9.16,
"high_60d": 11.93,
"low_60d": 7.53
},
"orb": {
"high": 11.9,
"low": 11.45,
"date": "2026-08-14"
},
"vwap": 11.61,
"volume_profile": {
"poc": 10.07,
"vah": 10.68,
"val": 9.51,
"sessions": 20
},
"recent_daily": [
{
"d": "2026-07-13",
"o": 9.7,
"h": 9.88,
"l": 9.19,
"c": 9.64,
"v": 1627557.297604
},
{
"d": "2026-07-14",
"o": 9.74,
"h": 10.16,
"l": 9.5501,
"c": 9.87,
"v": 1425091.307548
},
{
"d": "2026-07-15",
"o": 9.91,
"h": 9.98,
"l": 9.585,
"c": 9.64,
"v": 1158298.123133
},
{
"d": "2026-07-16",
"o": 9.55,
"h": 9.6719,
"l": 9.23,
"c": 9.48,
"v": 994706.62759
},
{
"d": "2026-07-17",
"o": 9.355,
"h": 10.5,
"l": 9.26,
"c": 10.18,
"v": 2380159.659131
},
{
"d": "2026-07-20",
"o": 10.18,
"h": 10.59,
"l": 9.55,
"c": 9.57,
"v": 1115404.80825
},
{
"d": "2026-07-21",
"o": 9.77,
"h": 10.29,
"l": 9.68,
"c": 10.22,
"v": 1284137.378797
},
{
"d": "2026-07-22",
"o": 10.14,
"h": 10.3,
"l": 9.985,
"c": 10.09,
"v": 779562.680987
},
{
"d": "2026-07-23",
"o": 9.91,
"h": 10.17,
"l": 9.82,
"c": 9.86,
"v": 766392.753998
},
{
"d": "2026-07-24",
"o": 9.86,
"h": 9.965,
"l": 9.455,
"c": 9.56,
"v": 1012021.022245
},
{
"d": "2026-07-27",
"o": 9.51,
"h": 10.2,
"l": 9.51,
"c": 9.96,
"v": 1272117.442416
},
{
"d": "2026-07-28",
"o": 9.76,
"h": 10.15,
"l": 9.56,
"c": 9.68,
"v": 1667317.895525
},
{
"d": "2026-07-29",
"o": 9.81,
"h": 9.85,
"l": 9.1612,
"c": 9.4,
"v": 1441345.804866
},
{
"d": "2026-07-30",
"o": 9.51,
"h": 9.95,
"l": 9.38,
"c": 9.87,
"v": 875603.230346
},
{
"d": "2026-07-31",
"o": 9.95,
"h": 10.13,
"l": 9.8,
"c": 10.01,
"v": 1117505.665044
},
{
"d": "2026-08-03",
"o": 9.97,
"h": 10.175,
"l": 9.51,
"c": 10.07,
"v": 879390.760443
},
{
"d": "2026-08-04",
"o": 10.15,
"h": 10.52,
"l": 10.09,
"c": 10.51,
"v": 1072773.55573
},
{
"d": "2026-08-05",
"o": 10.57,
"h": 10.815,
"l": 10.28,
"c": 10.46,
"v": 750662.627915
},
{
"d": "2026-08-06",
"o": 10.47,
"h": 10.7977,
"l": 10.42,
"c": 10.58,
"v": 1298231.894281
},
{
"d": "2026-08-07",
"o": 10.69,
"h": 10.74,
"l": 10.52,
"c": 10.59,
"v": 800789.031011
},
{
"d": "2026-08-10",
"o": 10.5,
"h": 10.66,
"l": 10.35,
"c": 10.5,
"v": 648486.76981
},
{
"d": "2026-08-11",
"o": 10.58,
"h": 10.69,
"l": 10.41,
"c": 10.65,
"v": 857172.606439
},
{
"d": "2026-08-12",
"o": 10.71,
"h": 10.9,
"l": 10.5,
"c": 10.68,
"v": 1378941.301852
},
{
"d": "2026-08-13",
"o": 10.85,
"h": 11.87,
"l": 10.475,
"c": 11.8,
"v": 2152443.446059
},
{
"d": "2026-08-14",
"o": 11.85,
"h": 11.93,
"l": 11.04,
"c": 11.84,
"v": 1647491.063256
}
]
}
Data:
{
"estimates": [
{
"symbol": "CADL",
"date": "2030-12-31",
"revenueLow": 173472851,
"revenueHigh": 1573422945,
"revenueAvg": 772772140,
"ebitdaLow": 34694570,
"ebitdaHigh": 314684588,
"ebitdaAvg": 154554427,
"ebitLow": 34694570,
"ebitHigh": 314684588,
"ebitAvg": 154554427,
"netIncomeLow": -2342531,
"netIncomeHigh": 672550430,
"netIncomeAvg": 286569819,
"sgaExpenseLow": 6968890148,
"sgaExpenseHigh": 63208805284,
"sgaExpenseAvg": 31044420625,
"epsAvg": 5.4112,
"epsHigh": 12.69954,
"epsLow": -0.04423322,
"numAnalystsRevenue": 5,
"numAnalystsEps": 2
},
{
"symbol": "CADL",
"date": "2029-12-31",
"revenueLow": 93292321,
"revenueHigh": 846174364,
"revenueAvg": 415590720,
"ebitdaLow": 18658464,
"ebitdaHigh": 169234872,
"ebitdaAvg": 83118143,
"ebitLow": 18658464,
"ebitHigh": 169234872,
"ebitAvg": 83118143,
"netIncomeLow": -1042792,
"netIncomeHigh": 299390048,
"netIncomeAvg": 127568372,
"sgaExpenseLow": 3747813753,
"sgaExpenseHigh": 33993193490,
"sgaExpenseAvg": 16695442876,
"epsAvg": 2.40883,
"epsHigh": 5.65328,
"epsLow": -0.0196907,
"numAnalystsRevenue": 3,
"numAnalystsEps": 3
},
{
"symbol": "CADL",
"date": "2028-12-31",
"revenueLow": 39600910,
"revenueHigh": 365712410,
"revenueAvg": 171015003,
"ebitdaLow": 7920181,
"ebitdaHigh": 73142481,
"ebitdaAvg": 34203000,
"ebitLow": 7920181,
"ebitHigh": 73142481,
"ebitAvg": 34203000,
"netIncomeLow": -80015216,
"netIncomeHigh": 225394641,
"netIncomeAvg": -77904500,
"sgaExpenseLow": 1590879437,
"sgaExpenseHigh": 14691691504,
"sgaExpenseAvg": 6870151512,
"epsAvg": 0.50697,
"epsHigh": 4.25605,
"epsLow": -1.5109,
"numAnalystsRevenue": 7,
"numAnalystsEps": 6
},
{
"symbol": "CADL",
"date": "2027-12-31",
"revenueLow": 8893549,
"revenueHigh": 76775416,
"revenueAvg": 42834483,
"ebitdaLow": 1778709,
"ebitdaHigh": 15355083,
"ebitdaAvg": 8566896,
"ebitLow": 1778709,
"ebitHigh": 15355083,
"ebitAvg": 8566896,
"netIncomeLow": -75806593,
"netIncomeHigh": 13676570,
"netIncomeAvg": -31065011.5,
"sgaExpenseLow": 357278765,
"sgaExpenseHigh": 3084283431,
"sgaExpenseAvg": 1720781118,
"epsAvg": -0.69358,
"epsHigh": 0.25825,
"epsLow": -1.43143,
"numAnalystsRevenue": 6,
"numAnalystsEps": 4
}
],
"price_target": {
"symbol": "CADL",
"targetHigh": 23,
"targetLow": 22,
"targetConsensus": 22.5,
"targetMedian": 22.5
},
"ratings": {
"symbol": "CADL",
"rating": "C-",
"overallScore": 1,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 2,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "CADL",
"date": "2026-03-18",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CADL",
"date": "2026-03-13",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CADL",
"date": "2026-03-13",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CADL",
"date": "2025-12-08",
"gradingCompany": "Stephens & Co.",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CADL",
"date": "2025-11-21",
"gradingCompany": "Freedom Broker",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CADL",
"date": "2025-11-14",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CADL",
"date": "2025-09-29",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CADL",
"date": "2025-09-03",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Neutral",
"action": "downgrade"
}
]
}
Data:
[
{
"title": "B of A Securities Maintains Neutral on Candel Therapeutics, Raises Price Target to $12",
"url": "https://www.benzinga.com/news/26/08/61223029/b-securities-maintains-neutral-candel-therapeutics-raises-price-target-12",
"source": "benzinga",
"date": "2026-08-14T18:23:48.589000+00:00",
"summary": "B of A Securities analyst Alec Stranahan maintains Candel Therapeutics (NASDAQ:CADL) with a Neutral and raises the price target from $9 to $12.",
"image": ""
},
{
"title": "Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights",
"url": "https://www.globenewswire.com/news-release/2026/08/13/3344478/0/en/candel-therapeutics-reports-second-quarter-2026-financial-results-and-recent-corporate-highlights.html",
"source": "GlobeNewsWire",
"date": "2026-08-13 08:05:00",
"summary": "NEEDHAM, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with cancer, today announced financial ",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-reports-second-quarter-2026-financial-results-and-20260813.jpg"
},
{
"title": "CADL Stock In Focus As Candel Nears Year-End BLA Filing For Prostate Cancer Drug -- Eyes $10-$16B Opportunity",
"url": "https://finance.yahoo.com/healthcare/articles/cadl-stock-focus-candel-nears-190832555.html",
"source": "Yahoo! Finance",
"date": "2026-08-12T19:08:32Z",
"summary": "* Chief Scientific Officer Dr. Francesca Barone said the company will present fresh analysis from the late-stage trial of CAN-2409 at the American Society for Radiation Oncology (ASTRO) Annual Meeting.\n\n* On the regulatory front, Barone emphasized steady progress on manufacturing",
"image": "https://s.yimg.com/lo/mysterio/api/C0AA587BD0DB6E32E933D692839DADBDF67E1CAEB3CD06935C3A3A9CCE721C22/subgraphmysterio/resizefill_w1200_h900;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fstocktwits_383%2F4214a6f23dbcee89544fc474c7be93e7.jpg"
},
{
"title": "Candel Therapeutics Eyes 2026 Prostate Cancer Filing as Lung Study Ramps Up",
"url": "https://finance.yahoo.com/healthcare/articles/candel-therapeutics-eyes-2026-prostate-170455210.html",
"source": "Yahoo! Finance",
"date": "2026-08-12T17:04:55Z",
"summary": "* Unusually High Volume Points to Upside in These Stocks\n\nCandel Therapeutics (NASDAQ:CADL) is advancing two off-the-shelf viral immunotherapy candidates designed for local administration intended to generate systemic immune responses against tumors, Chief Scientific Officer Fran",
"image": "https://s.yimg.com/lo/mysterio/api/A65452737A74E797A5903D908C8CE837CA4701347BFB5A2F6790D2F29167AC1D/subgraphmysterio/resizefill_w1200_h675;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmarketbeat_955%2F4e2509f413cdca5a69247986fadf1c04.png"
},
{
"title": "Candel Therapeutics at canaccord growth conference: prostate cancer push By Investing.com",
"url": "https://www.investing.com/news/transcripts/candel-therapeutics-at-canaccord-growth-conference-prostate-cancer-push-93CH-4855719",
"source": "Investing.com",
"date": "2026-08-12T16:46:45Z",
"summary": "Candel Therapeutics (CADL) used Wednesday, 12 August 2026, at Canaccord Genuity's 46th Annual Growth Conference to outline a pipeline built around off-the-shelf viral immunotherapies aimed at local delivery and systemic immune activation. Chief Scientific Officer Dr. Francesca Ba",
"image": "https://content-media.investing.com/news/LYNXMPEB59082_L.jpg"
},
{
"title": "Candel Therapeutics: Getting Closer, And Building Out More Paths",
"url": "https://seekingalpha.com/article/4933126-candel-therapeutics-getting-closer-and-building-out-more-paths",
"source": "Seeking Alpha",
"date": "2026-08-07 11:08:21",
"summary": "Candel Therapeutics, Inc. remains a Buy as its lead asset, CAN-2409, advances toward FDA submission in prostate cancer with strong phase 3 data. CADL is well-capitalized, holding $194.8M in cash, providing runway into Q1 2028 and supporting pivotal trials in prostate and lung can",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-getting-closer-and-building-out-more-paths-20260807.jpg"
},
{
"title": "Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/08/03/3337872/0/en/Candel-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html",
"source": "GlobeNewsWire",
"date": "2026-08-03 16:05:00",
"summary": "NEEDHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced th",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-20260803.jpg"
},
{
"title": "Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026",
"url": "https://www.globenewswire.com/news-release/2026/08/03/3337474/0/en/Candel-Therapeutics-to-Present-Extended-Data-from-Phase-3-Results-of-Aglatimagene-Besadenovec-at-ASTRO-2026.html",
"source": "GlobeNewsWire",
"date": "2026-08-03 08:05:00",
"summary": "NEEDHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced th",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-to-present-extended-data-from-phase-3-20260803.jpg"
},
{
"title": "Candel Therapeutics to Present at Canaccord Genuity's 46th Annual Growth Conference in Boston",
"url": "https://www.globenewswire.com/news-release/2026/07/29/3335184/0/en/candel-therapeutics-to-present-at-canaccord-genuity-s-46th-annual-growth-conference-in-boston.html",
"source": "GlobeNewsWire",
"date": "2026-07-29 08:05:00",
"summary": "NEEDHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced th",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-to-present-at-canaccord-genuitys-46th-annual-20260729.jpg"
},
{
"title": "Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/07/08/3324419/0/en/Candel-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html",
"source": "GlobeNewsWire",
"date": "2026-07-08 16:05:00",
"summary": "NEEDHAM, Mass., July 08, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced th",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-20260708.jpg"
},
{
"title": "Candel Therapeutics: An Overlooked Late-Stage Biotech With Real Potential",
"url": "https://seekingalpha.com/article/4919788-candel-therapeutics-an-overlooked-late-stage-biotech-with-real-potential",
"source": "Seeking Alpha",
"date": "2026-07-04 02:06:05",
"summary": "Candel Therapeutics is transitioning from a high-risk clinical-stage biotech to a late-stage oncology company with a BLA-directed lead asset. CAN-2409 has achieved positive Phase III results in localized prostate cancer, with additional promising data in NSCLC and PDAC, supportin",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-an-overlooked-latestage-biotech-with-real-potential-20260704.jpg"
},
{
"title": "Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors",
"url": "https://www.globenewswire.com/news-release/2026/06/30/3319644/0/en/candel-therapeutics-announces-initiation-of-global-pivotal-phase-3-aurora-trial-evaluating-aglatimagene-besadenovec-can-2409-in-advanced-non-small-cell-lung-cancer-patients-with-in.html",
"source": "Globe News Wire",
"date": "2026-06-30 08:05:00",
"summary": "Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab versus standard-of-care docetaxel chemotherapy in patients with metastatic, non-squamous, non-small cell lung cancer (NSCLC) with progressive disease despit",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-announces-initiation-of-global-pivotal-phase-3-20260630.png"
},
{
"title": "Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer",
"url": "https://www.globenewswire.com/news-release/2026/06/25/3317499/0/en/Candel-Therapeutics-Appoints-Mark-Sims-as-Chief-Commercial-Officer.html",
"source": "GlobeNewsWire",
"date": "2026-06-25 08:05:00",
"summary": "NEEDHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced th",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-appoints-mark-sims-as-chief-commercial-officer-20260625.jpg"
},
{
"title": "Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer",
"url": "https://www.globenewswire.com/news-release/2026/06/02/3305133/0/en/Candel-Therapeutics-Announces-Publication-in-The-Lancet-Oncology-of-Pivotal-Phase-3-Data-Demonstrating-Significant-Improvement-in-Disease-Free-Survival-with-Aglatimagene-Besadenove.html",
"source": "GlobeNewsWire",
"date": "2026-06-02 08:05:00",
"summary": "NEEDHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced th",
"image": "https://images.financialmodelingprep.com/news/candel-therapeutics-announces-publication-in-the-lancet-oncology-of-20260602.jpg"
},
{
"title": "Stock Market Today: Dow Jones, S&P 500 Futures Slip After Weaker-Than-Expected GDP Report\u2014Grail, Candel Therapeutics, Copart In Focus (UPDATED)",
"url": "https://www.benzinga.com/markets/equities/26/02/50743289/stock-market-today-dow-jones-sp-500-futures-rise-ahead-of-q4-gdp-numbers-grail-candel-therapeuti?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-02-20T13:56:04Z",
"summary": "U.S. stock futures rose on Friday ahead of Q4 GDP data and PCE inflation gauge releases. Markets are pricing in a 94% likelihood of unchanged Fed rates in March. Notable movers include Copart missing earnings expectations, Comfort Systems raising dividends, Grail plunging 47% on ",
"image": "https://cdn.benzinga.com/files/images/story/2026/02/20/Wall-Street.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "Candel Therapeutics Announces Pricing of Public Offering",
"url": "https://www.globenewswire.com/news-release/2026/02/20/3241663/0/en/Candel-Therapeutics-Announces-Pricing-of-Public-Offering.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-20T02:40:00Z",
"summary": "Candel Therapeutics announced a public offering of 18.3 million shares at $5.45 per share, raising $100 million in gross proceeds. The company plans to use the funds for launch readiness and commercialization of aglatimagene besadenovec for localized prostate cancer, ongoing phas",
"image": "https://ml.globenewswire.com/Resource/Download/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0"
},
{
"title": "Candel Therapeutics Announces Proposed $100 Million Public Offering",
"url": "https://www.benzinga.com/pressreleases/26/02/g50734512/candel-therapeutics-announces-proposed-100-million-public-offering?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-02-19T21:05:00Z",
"summary": "Candel Therapeutics (NASDAQ: CADL) announced a proposed $100 million public offering of common stock, with an additional $15 million option for underwriters. The company plans to use proceeds for launch readiness, commercialization activities, and development of aglatimagene for ",
"image": "https://www.benzinga.com/next-assets/images/benzinga-schema-image-default.png"
},
{
"title": "Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031",
"url": "https://www.globenewswire.com/news-release/2026/01/23/3224533/28124/en/Oncolytic-Virotherapy-Market-Global-Industry-Size-Share-Trends-Opportunity-and-Forecast-2021-2031.html",
"source": "GlobeNewswire Inc.",
"date": "2026-01-23T10:52:00Z",
"summary": "The global oncolytic virotherapy market is projected to grow from USD 49.73 million in 2025 to USD 153.31 million by 2031, with a CAGR of 20.64%. Growth is driven by rising cancer incidence, advances in genetic engineering, and synergistic combination therapies with checkpoint in",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors",
"url": "https://www.globenewswire.com/news-release/2025/11/04/3180386/0/en/Candel-Therapeutics-Showcases-Immunotherapy-Leadership-at-SITC-2025-Demonstrating-Integration-of-Clinical-Innovation-Multi-Omics-and-Artificial-Intelligence-to-Advance-Next-Generat.html",
"source": "GlobeNewswire Inc.",
"date": "2025-11-04T14:00:00Z",
"summary": "Candel Therapeutics presented three key research presentations at SITC 2025, highlighting advances in immunotherapy for solid tumors using multi-omics analysis and artificial intelligence, including promising phase 3 clinical trial results for CAN-2409 in prostate cancer and prec",
"image": "https://ml.globenewswire.com/Resource/Download/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0"
}
]
Data:
[
{
"symbol": "CADL",
"date": "2026-11-12",
"epsActual": null,
"epsEstimated": -0.26,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-08-14"
},
{
"symbol": "CADL",
"date": "2026-08-13",
"epsActual": -0.52,
"epsEstimated": -0.27379,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-08-14"
},
{
"symbol": "CADL",
"date": "2026-05-14",
"epsActual": -0.14,
"epsEstimated": -0.22,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-08-14"
},
{
"symbol": "CADL",
"date": "2026-03-12",
"epsActual": -0.54,
"epsEstimated": -0.24,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-06-12"
},
{
"symbol": "CADL",
"date": "2025-11-13",
"epsActual": -0.21,
"epsEstimated": -0.17,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-02-13"
},
{
"symbol": "CADL",
"date": "2025-08-14",
"epsActual": -0.09,
"epsEstimated": -0.17,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2025-11-14"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "CADL",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "CADL",
"periods": [
{
"file_period": "202603b",
"settlement_date": "20260330",
"quantity_fails": 6812,
"price": 4.81
},
{
"file_period": "202604a",
"settlement_date": "20260409",
"quantity_fails": 4159,
"price": 4.95
},
{
"file_period": "202604b",
"settlement_date": "20260423",
"quantity_fails": 1,
"price": 7.34
},
{
"file_period": "202606a",
"settlement_date": "20260609",
"quantity_fails": 2597,
"price": 8.5
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 62751,
"price": 10.36
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 134,
"price": 9.64
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "CADL",
"filingDate": "2026-07-08",
"transactionDate": "2026-07-06",
"reportingCik": "0002139479",
"companyCik": "0001841387",
"transactionType": "A-Award",
"securitiesOwned": 285000,
"reportingName": "Sims Mark E.",
"typeOfOwner": "officer: Chief Commercial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 285000,
"price": 10.03,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000213947926000004/0002139479-26-000004-index.htm"
},
{
"symbol": "CADL",
"filingDate": "2026-07-08",
"transactionDate": "2026-07-06",
"reportingCik": "0002139479",
"companyCik": "0001841387",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Sims Mark E.",
"typeOfOwner": "",
"acquisitionOrDisposition": "",
"directOrIndirect": null,
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000213947926000003/0002139479-26-000003-index.htm"
},
{
"symbol": "CADL",
"filingDate": "2026-07-01",
"transactionDate": "2026-06-29",
"reportingCik": "0001909680",
"companyCik": "0001841387",
"transactionType": "S-Sale",
"securitiesOwned": 77362,
"reportingName": "Barone Francesca",
"typeOfOwner": "officer: Chief Scientific Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 23447,
"price": 10.0554,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000190968026000002/0001909680-26-000002-index.htm"
},
{
"symbol": "CADL",
"filingDate": "2026-07-01",
"transactionDate": "2026-06-29",
"reportingCik": "0001923794",
"companyCik": "0001841387",
"transactionType": "S-Sale",
"securitiesOwned": 83865,
"reportingName": "Tyagarajan Seshu",
"typeOfOwner": "officer: Chief Technology Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7000,
"price": 10.0216,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000192379426000002/0001923794-26-000002-index.htm"
},
{
"symbol": "CADL",
"filingDate": "2026-07-01",
"transactionDate": "2026-06-30",
"reportingCik": "0001494695",
"companyCik": "0001841387",
"transactionType": "A-Award",
"securitiesOwned": 2199,
"reportingName": "Manning Paul B",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2199,
"price": 10.3,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000149469526000018/0001494695-26-000018-index.htm"
},
{
"symbol": "CADL",
"filingDate": "2026-07-01",
"transactionDate": "2026-06-30",
"reportingCik": "0001242215",
"companyCik": "0001841387",
"transactionType": "A-Award",
"securitiesOwned": 1331,
"reportingName": "PAPA JOSEPH C",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1331,
"price": 10.3,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000124221526000018/0001242215-26-000018-index.htm"
},
{
"symbol": "CADL",
"filingDate": "2026-07-01",
"transactionDate": "2026-06-30",
"reportingCik": "0001979825",
"companyCik": "0001841387",
"transactionType": "A-Award",
"securitiesOwned": 381,
"reportingName": "Loggia Nicoletta",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 381,
"price": 10.3,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000197982526000006/0001979825-26-000006-index.htm"
},
{
"symbol": "CADL",
"filingDate": "2026-06-24",
"transactionDate": "2026-06-23",
"reportingCik": "0002013423",
"companyCik": "0001841387",
"transactionType": "A-Award",
"securitiesOwned": 32000,
"reportingName": "Radhakrishnan Maha",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 32000,
"price": 9.08,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1841387/000201342326000004/0002013423-26-000004-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:40.085000Z",
"size": 6100.0,
"price": 11.82,
"premium": 72102.0,
"volume": 6100.0,
"trade_code": " "
},
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:40.085000Z",
"size": 6100.0,
"price": 11.82,
"premium": 72102.0,
"volume": 6100.0,
"trade_code": " "
},
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:19.382000Z",
"size": 700.0,
"price": 11.795,
"premium": 8256.5,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:07.014000Z",
"size": 550.0,
"price": 11.795,
"premium": 6487.25,
"volume": 550.0,
"trade_code": " "
},
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:07.013000Z",
"size": 540.0,
"price": 11.7925,
"premium": 6367.95,
"volume": 540.0,
"trade_code": " "
},
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:07.021000Z",
"size": 500.0,
"price": 11.795,
"premium": 5897.5,
"volume": 500.0,
"trade_code": " "
},
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:55.273000Z",
"size": 400.0,
"price": 11.81,
"premium": 4724.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "CADL",
"executed_at": "2026-08-14T19:47:58.016000Z",
"size": 200.0,
"price": 11.81,
"premium": 2362.0,
"volume": 200.0,
"trade_code": " "
}
],
"ats": {
"symbol": "CADL",
"date": "20260813",
"ats_volume": 0,
"total_volume": 967748,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260813",
"ats_ratio": 0.0
},
{
"date": "20260812",
"ats_ratio": 0.0
},
{
"date": "20260811",
"ats_ratio": 0.0
},
{
"date": "20260810",
"ats_ratio": 0.0
},
{
"date": "20260807",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "CADL",
"days": [
{
"date": "2026-08-14",
"close": 11.81,
"vwap": 11.62,
"volume": 1681242,
"vwap_discount_pct": -1.65
},
{
"date": "2026-08-13",
"close": 11.8,
"vwap": 11.38,
"volume": 2152443,
"vwap_discount_pct": -3.6
},
{
"date": "2026-08-12",
"close": 10.68,
"vwap": 10.7,
"volume": 1378941,
"vwap_discount_pct": 0.19
},
{
"date": "2026-08-11",
"close": 10.65,
"vwap": 10.58,
"volume": 857172,
"vwap_discount_pct": -0.68
},
{
"date": "2026-08-10",
"close": 10.5,
"vwap": 10.49,
"volume": 648486,
"vwap_discount_pct": -0.11
}
],
"avg_vwap_discount_pct": -1.17,
"signal": "Distribution"
},
"options_flow": [],
"net_premium": {
"ticker": "CADL",
"net_call_premium": "-6631.00",
"net_put_premium": "-2769.00",
"call_premium": "128995.00",
"put_premium": "101318.00",
"bullish_premium": "104873.00",
"bearish_premium": "108735.00",
"put_call_ratio": "0.95021645021645021645",
"iv_rank": "29.5261",
"implied_move_perc": "0.202000",
"gex_ratio": "0.30103956124634863712",
"gex_net_change": "4563.2198",
"gex_call": "51668.7210",
"gex_put": "-15554.3291",
"gex_net": 36114.3919,
"gex_call_delta": "620434.7741",
"gex_put_delta": "-90276.3806",
"gex_date": "2026-08-14"
},
"hot_chains": [
{
"underlying_symbol": "CADL",
"expires": "2027-01-15",
"open_interest": 31,
"option_type": "put",
"delta": -0.402998454144301,
"ask_volume": 98,
"last_price": "2.50",
"implied_volatility": "0.825656171343005",
"gamma": 0.0595443195232744,
"avg_price": "2.6966346153846153846153846156",
"bid_volume": 98,
"nbbo_ask": "3.70",
"strike": "12",
"option_symbol": "CADL270115P00012000",
"total_premium": "56090.00",
"iv": 0.847659932931157,
"volume": 208,
"nbbo_bid": "2.25"
},
{
"underlying_symbol": "CADL",
"expires": "2027-01-15",
"open_interest": 349,
"option_type": "put",
"delta": -0.34311818840323,
"ask_volume": 100,
"last_price": "2.00",
"implied_volatility": "0.831074148623634",
"gamma": 0.0564174923674521,
"avg_price": "2.1284057971014492753623188399",
"bid_volume": 87,
"nbbo_ask": "3.60",
"strike": "11",
"option_symbol": "CADL270115P00011000",
"total_premium": "44058.00",
"iv": 0.84978575080054,
"volume": 207,
"nbbo_bid": "1.75"
},
{
"underlying_symbol": "CADL",
"expires": "2026-10-16",
"open_interest": 271,
"option_type": "call",
"delta": 0.909023562113485,
"ask_volume": 94,
"last_price": "4.97",
"implied_volatility": "1.060465447573304",
"gamma": 0.0290924839552694,
"avg_price": "4.8896019900497512437810945272",
"bid_volume": 95,
"nbbo_ask": "6.00",
"strike": "7",
"option_symbol": "CADL261016C00007000",
"total_premium": "98281.00",
"iv": 1.147203808061175,
"volume": 201,
"nbbo_bid": "4.70"
},
{
"underlying_symbol": "CADL",
"expires": "2026-09-18",
"open_interest": 1,
"option_type": "call",
"delta": 0.41374668584775,
"ask_volume": 0,
"last_price": "0.75",
"implied_volatility": "0.785147445986616",
"gamma": 0.1211826071524095,
"avg_price": "0.75",
"bid_volume": 100,
"nbbo_ask": "1.20",
"strike": "13",
"option_symbol": "CADL260918C00013000",
"total_premium": "7500.00",
"iv": 0.879329899469221,
"volume": 100,
"nbbo_bid": "0.50"
},
{
"underlying_symbol": "CADL",
"expires": "2027-01-15",
"open_interest": 16,
"option_type": "call",
"delta": 0.334778258014384,
"ask_volume": 40,
"last_price": "1.15",
"implied_volatility": "0.896984421951536",
"gamma": 0.0526438042695257,
"avg_price": "1.1546511627906976744186046512",
"bid_volume": 3,
"nbbo_ask": "1.15",
"strike": "18",
"option_symbol": "CADL270115C00018000",
"total_premium": "4965.00",
"iv": 0.902121587741304,
"volume": 43,
"nbbo_bid": "0.80"
},
{
"underlying_symbol": "CADL",
"expires": "2026-10-16",
"open_interest": 85,
"option_type": "call",
"delta": 0.0883862188311651,
"ask_volume": 30,
"last_price": "0.33",
"implied_volatility": "0.888309509918536",
"gamma": 0.0480771904680951,
"avg_price": "0.33",
"bid_volume": 0,
"nbbo_ask": "0.50",
"strike": "18",
"option_symbol": "CADL261016C00018000",
"total_premium": "990.00",
"iv": 0.678577275002237,
"volume": 30,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "CADL",
"expires": "2027-01-15",
"open_interest": 59,
"option_type": "call",
"delta": 0.55146881026444,
"ask_volume": 10,
"last_price": "2.19",
"implied_volatility": "0.909777504261931",
"gamma": 0.057073717430146,
"avg_price": "2.4700000000000000000000000000",
"bid_volume": 10,
"nbbo_ask": "3.50",
"strike": "13",
"option_symbol": "CADL270115C00013000",
"total_premium": "4940.00",
"iv": 0.903834341724857,
"volume": 20,
"nbbo_bid": "1.65"
},
{
"underlying_symbol": "CADL",
"expires": "2026-08-21",
"open_interest": 35,
"option_type": "call",
"delta": 0.001768628256496611,
"ask_volume": 0,
"last_price": "0.10",
"implied_volatility": "1.98810335765072",
"gamma": 0.00340122706322477,
"avg_price": "0.2181818181818181818181818182",
"bid_volume": 11,
"nbbo_ask": "0.25",
"strike": "18",
"option_symbol": "CADL260821C00018000",
"total_premium": "240.00",
"iv": 1.019079947123874,
"volume": 11,
"nbbo_bid": "0.00"
}
],
"gamma_profile": {
"ticker": "CADL",
"spot": 11.83,
"date": "2026-08-14",
"flip_point": 3.07,
"net_gex": 36114.39,
"call_walls": [
{
"strike": 11.0,
"gex": 18068.92
},
{
"strike": 10.0,
"gex": 10415.49
},
{
"strike": 12.0,
"gex": 7148.88
}
],
"put_walls": [
{
"strike": 9.0,
"gex": -5951.92
},
{
"strike": 10.0,
"gex": -2353.0
},
{
"strike": 11.0,
"gex": -2352.47
}
],
"by_strike": [
{
"strike": 1.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 2.0,
"call_gex": 0.0,
"put_gex": -0.05,
"net_gex": -0.05
},
{
"strike": 3.0,
"call_gex": 0.6,
"put_gex": -6.18,
"net_gex": -5.58
},
{
"strike": 4.0,
"call_gex": 156.03,
"put_gex": -69.69,
"net_gex": 86.34
},
{
"strike": 5.0,
"call_gex": 530.32,
"put_gex": -59.92,
"net_gex": 470.4
},
{
"strike": 6.0,
"call_gex": 978.81,
"put_gex": -342.96,
"net_gex": 635.85
},
{
"strike": 7.0,
"call_gex": 3503.33,
"put_gex": -185.74,
"net_gex": 3317.58
},
{
"strike": 8.0,
"call_gex": 3034.94,
"put_gex": -1440.58,
"net_gex": 1594.36
},
{
"strike": 9.0,
"call_gex": 3894.14,
"put_gex": -5951.92,
"net_gex": -2057.78
},
{
"strike": 10.0,
"call_gex": 10415.49,
"put_gex": -2353.0,
"net_gex": 8062.49
},
{
"strike": 11.0,
"call_gex": 18068.92,
"put_gex": -2352.47,
"net_gex": 15716.45
},
{
"strike": 12.0,
"call_gex": 7148.88,
"put_gex": -697.21,
"net_gex": 6451.67
},
{
"strike": 13.0,
"call_gex": 650.22,
"put_gex": -1003.13,
"net_gex": -352.91
},
{
"strike": 14.0,
"call_gex": 1305.86,
"put_gex": -926.77,
"net_gex": 379.09
},
{
"strike": 15.0,
"call_gex": 948.3,
"put_gex": -164.69,
"net_gex": 783.6
},
{
"strike": 16.0,
"call_gex": 103.27,
"put_gex": 0.0,
"net_gex": 103.27
},
{
"strike": 17.0,
"call_gex": 158.14,
"put_gex": 0.0,
"net_gex": 158.14
},
{
"strike": 18.0,
"call_gex": 771.48,
"put_gex": 0.0,
"net_gex": 771.48
}
]
},
"oi_changes": {
"net_call_oi_change": 115,
"net_put_oi_change": 1,
"top": [
{
"strike": "10",
"oi_change": 77,
"type": "call"
},
{
"strike": "12",
"oi_change": 38,
"type": "call"
},
{
"strike": "11",
"oi_change": 12,
"type": "call"
},
{
"strike": "6",
"oi_change": -10,
"type": "call"
},
{
"strike": "9",
"oi_change": -2,
"type": "call"
}
]
}
}
Data:
{
"vix": 15.28,
"sp500": 7728.2,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.48,
"hy_spread": 2.7,
"treasury": {
"date": "2026-08-12",
"month1": 3.78,
"month2": 3.8,
"month3": 3.87,
"month6": 3.97,
"year1": 4,
"year2": 4.2,
"year3": 4.25,
"year5": 4.38,
"year7": 4.52,
"year10": 4.68,
"year20": 5.24,
"year30": 5.24
},
"events": []
}
Data:
{
"days": 46,
"patterns": [
{
"name": "VWAP Touch",
"count": 46,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 46,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 46,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 45,
"pct": 98
},
{
"name": "Woodie Pivot Touch",
"count": 45,
"pct": 98
},
{
"name": "PDH/PDL Touch",
"count": 40,
"pct": 87
},
{
"name": "Open Retracement",
"count": 36,
"pct": 78
},
{
"name": "Gap Fill",
"count": 34,
"pct": 74
},
{
"name": "Darvas Box",
"count": 31,
"pct": 67
},
{
"name": "Power Hour",
"count": 9,
"pct": 20
},
{
"name": "High Vol Open",
"count": 9,
"pct": 20
}
]
}